Poor prognosis of single hormone receptorpositive breast cancer: Similar outcome as triple-negative breast cancer

Response to endocrine therapy in breast cancer correlates with estrogen receptor (ER) and progesterone receptor (PR) status. Generally, hormone receptor-positive (HR+) breast cancers have favorable prognosis.